This study assessed the costs and benefits of introducing routine vari
cella vaccination to healthy children in Germany, Three vaccination st
rategies were compared with that of no prevention: vaccination of all
15-month-old children; vaccination of susceptible 12-year-olds (adoles
cent); and a combination of strategies (children including catch-up),
From a purely economic viewpoint, the adolescent strategy was optimal:
It was the only one that resulted in net direct cost savings, However
, since this strategy may be less acceptable from a medical or organiz
ational point of view and because total net savings were the highest,
a second option was to begin immunization starting with the 15-month-o
ld children and to use the catch-up strategy for 11 years (total benef
it-to-cost ratio (BCR), 4.72:1; cost-effectiveness ratio (CER), DM 691
5 per life-year saved) and from year 12 on to use the first strategy (
BCR, 4.60:1; CER, DM 19,735 per life-year saved).